New antibody aims to supercharge immune attack on tumors
Disease control
Recruiting now
This early-stage trial tests a new drug called MST-0312 in people with advanced solid tumors like lung, melanoma, bladder, colorectal, and triple-negative breast cancer. The drug is designed to activate a natural immune pathway to help the body fight cancer more effectively. It i…
Phase: PHASE1 • Sponsor: Mestag Therapeutics Limited • Aim: Disease control
Last updated Jun 16, 2026 12:50 UTC